Assessing Funding and Outsourcing Behavior
Our team surveyed executives, financial officers, and R&D leaders at small and mid-sized biotech companies in North America to understand their strategies for attracting investor funding and how they allocate those resources, particularly in relation to outsourcing during a period of economic downturn. The survey provided a detailed analysis of biotech funding dynamics and outsourcing behaviors and offered insights that Scorpius used to generate leads and strengthen its position as a biologics CDMO focused on early-stage biotech clients, helping to tailor its offerings to better meet their needs.
